Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.08.22.671660

Neutral mutation disequilibrium is common in prokaryotes and animals

Abstract

Widely used models of sequence evolution assume DNA sequences are at equilibrium with respect to the processes that drive divergence, mutation and natural selection. Violations of this assumption have been shown to affect the conclusions from analyses of genetic variation. However, there is currently a lack of statistical methods to assess whether this phenomenon occurs with sufficient frequency and magnitude to warrant concern. Here, we introduce such techniques and apply them to cases where genetically encoded changes to mutation are expected to induce neutral mutation disequilibrium (NMD) across an entire genome (loss of the hypermutable base 5-methyl-cytosine in Drosophila melanogaster), or in a limited genomic region (translocation of the Fxy gene to the pseudo-autosomal region in Mus musculus). We find that the proportion of 9,237 genes in NMD in the D. melanogaster genome ([~]0.81) is markedly elevated compared to its sister taxa D. simulans ([~]0.31) which retains 5-methyl-cytosine. We further establish that the translocation of Fxy has resulted in a [~] 3x increase in the magnitude of NMD. These empirical case studies validate the robustness of our methods. Applying the methods to human evolution, from 613 genes, we estimated the proportion of NMD for the exons as [~]0.64 and introns as [~]0.22. These results establish NMD as a common phenomenon and suggest that conclusions from studies that assumed equilibrium in order to understand biological mechanisms may misattribute to biology what should be credited to measurement error. SignificanceIt has been famously said that all models are wrong, but some are useful. Statistical models of sequence divergence provide the fundamental quantities from which we derive meaning about the causative mechanisms responsible for patterns in molecular evolution. Published work has established current models are not just wrong, but misleading - incorrectly assuming neutral mutation equilibrium leads to errors in the inference of the mode of natural selection and the existence of the molecular clock. In this work, we demonstrate that neutral mutation disequilibrium is common, suggesting that these errors may be widespread. Our results raise the strong likelihood that detected patterns in molecular evolution are being misattributed to biological mechanisms when, in fact, they reflect systematic measurement error.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Caley, K., Kaehler, B., Yap, V. B., Huttley, G. A.. 2025-08-22. Neutral mutation disequilibrium is common in prokaryotes and animals. https://doi.org/10.1101/2025.08.22.671660

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD

Progressive hepatic fibrosis is the principal determinant of morbidity and mortality in metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH). Mitochondrial dysfunction is a hallmark of MASH, and the release of mitochondrial damage-associated molecular patterns (mito-DAMPs) from injured hepatocytes can promote fibrosis. However, how mitochondrial dynamics and quality control shape the fibrotic response in MASLD/MASH remains unclear. Here, through large-scale genomic analyses of mitochondrial genes governing mitophagy, fusion and fission in human MASLD, with a power-equivalent sample size of approximately 700,000 individuals, we identify a strong association between hepatic fibrosis and the mitochondrial fusion factor dynamin-like GTPase optic atrophy 1 (OPA1). OPA1 transcripts and protein abundance in the liver epithelium were progressively dysregulated with advancing fibrosis. In mice, hepatocyte-specific OPA1 loss alone was sufficient to induce hepatic stellate cell activation and fibrosis in zone 3, promoted the release of mito-DAMPs into the circulation and exacerbated fibrosis in experimental MASH. These findings identify OPA1 as a central regulator of the hepatic fibrotic response and connect defective mitochondrial homeostasis to mito-DAMP release, hepatic stellate cell activation and fibrosis in MASLD.

genetics↗

Temporal control of mitochondrial mutagenesis reveals the fate of mtDNA mutations with age

Mutations in the mitochondrial genome (mtDNA) play a critical role in the aging process and a wide variety of age-related diseases. However, it remains unclear when the mutations that drive physiological decline arise. To answer this question, we generated a new mouse model in which mitochondrial mutagenesis can be confined to a defined window of time. Surprisingly, we found that mutations that arise during the first two months of life are sufficient to drive a wide variety of age-related pathologies, and that the severity of this pathology is broadly regulated by distinct, tissue-specific selective pressures that control the fate of mtDNA mutations with age. Further, we found that selection against deleterious variants can be modulated by manipulation of mitochondrial fusion in vitro and in vivo. These observations raise the possibility that in some tissues, the pace of aging is pre-determined by events that occur early in life and that interventions targeting mitochondrial fusion may be able to slow down or reverse the expansion of these pathogenic variants. These results carry far-reaching implications for strategies aimed at preventing or delaying age-related decline.

genetics↗

Innate immune stress pathway activation underlies heterochromatin dysfunction pathology

Heterochromatin loss disrupts nuclear architecture, gene regulation and repetitive element silencing, and is associated with diverse human diseases. However, mechanisms linking heterochromatin dysfunction to pathological phenotypes remain unclear. Using genetic interaction screening and genomic analyses in C. elegans, we identify secondary activation of the Intracellular Pathogen Response (IPR), an innate immune stress pathway, as a major contributor to heterochromatin mutant phenotypes. Constitutive IPR activation phenocopies slow growth and indirect transcriptional changes observed in these mutants. Depletion of genetic enhancers further increased, whereas suppressor RNAi attenuated IPR activation, with direct heterochromatin targets remaining substantially deregulated. Notably, many suppressors encode active chromatin components, and mild reduction of RNA polymerase II activity ameliorates growth defects in C. elegans HP1 mutants and human HP1-deficient cells. Our findings reveal secondary stress response activation as an important mechanism linking heterochromatin dysfunction to pathology and identify transcriptional dampening as a potential therapeutic strategy for mitigating these effects.

genetics↗